Dolby Laboratories Crecimiento futuro
Future controles de criterios 1/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Dolby Laboratories de 14.2% y 4.8% respectivamente, mientras que el BPA crecerá en un 15.6% al año.
Información clave
14.2%
Tasa de crecimiento de los beneficios
15.62%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Software | 19.8% |
| Tasa de crecimiento de los ingresos | 4.8% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 05 May 2026 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Actualización de narrativa • May 17
DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains
Analysts have nudged their price target for Dolby Laboratories down from about $81 to roughly $78, reflecting updated assumptions that combine slightly adjusted revenue growth and discount rate inputs with a different outlook on profit margins and future P/E levels. What's in the News Dolby repurchased 1,010,900 shares between December 27, 2025 and March 27, 2026 for US$65 million, bringing total buybacks under its November 3, 2009 authorization to 54,327,604 shares (52.77%) for US$3,159.61 million (company buyback filing).Seeking Alpha • May 03
Dolby: I Don't Mind Waiting In 2026
Summary Dolby Labs is rated a 'BUY' with a conservative $80/share price target, reflecting 17–25% annualized upside potential through 2028. DLB trades at a rare sub-15x P/E, supported by robust patent-driven recurring revenue, high margins, and a net cash balance exceeding $500M. Despite cyclical end-market exposure and recent earnings volatility, DLB's technology leadership and dominant licensing position underpin long-term revenue security. A dividend yield of 2.5%, ongoing buybacks at attractive valuations, and minimal inflation sensitivity further strengthen the investment case. Read the full article on Seeking AlphaActualización de narrativa • May 01
DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains
Analysts have adjusted their price target for Dolby Laboratories from $90.50 to $81.00, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Dolby Atmos is being introduced in the new BMW 7 Series through BMW's Bowers & Wilkins Diamond Surround Sound System, which includes up to 36 speakers and 1,965 watts and is aimed at creating a three-dimensional in-car listening experience (Key Developments).
Actualización de narrativa • Apr 17
DLB: Expanding Premium Cinema Footprint And Ongoing Buybacks Will Support Upside
Analysts are keeping their price target for Dolby Laboratories steady at $90.00. They point to only minor adjustments in the discount rate, revenue growth assumptions and profit margin outlook, along with a slightly lower future P/E multiple in their refreshed models.Actualización de narrativa • Apr 03
DLB: Future Streaming Expansion And Ongoing Buybacks Will Support Upside Outlook
Analysts have maintained their $90.00 price target for Dolby Laboratories, reflecting updated assumptions that include a slightly lower discount rate, modestly higher revenue growth and profit margin, and a slightly reduced future P/E multiple. What's in the News From September 27, 2025 to December 26, 2025, Dolby repurchased 1,044,838 shares for US$70 million, representing 1.09% of shares, completing a total of 53,316,704 shares repurchased for US$3,094.61 million under the buyback announced on November 3, 2009 (company filing).Actualización de narrativa • Mar 19
DLB: Future Streaming Technology Adoption Will Support A More Optimistic Outlook
Analysts have revised their price target for Dolby Laboratories from $114.00 to $90.00. They cite updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change.
Actualización de narrativa • Mar 05
DLB: Media Partnerships And Buybacks Will Support Measured Future Returns
Analysts are keeping their price target for Dolby Laboratories steady at $68.00. This points to largely unchanged expectations around fair value, discount rate, revenue growth, profit margin and future P/E assumptions.Actualización de narrativa • Feb 19
DLB: Broad Media Partnerships And Buybacks Will Support Steady Returns
Analysts maintained their Dolby Laboratories fair value estimate at $68.00, with only minor adjustments to assumptions around discount rate, revenue growth, profit margin, and future P/E informing the updated price target rationale. What's in the News Dolby updated earnings guidance for the second quarter of fiscal 2026, with total revenue estimated at US$375 million to US$405 million and GAAP diluted EPS expected at US$0.94 to US$1.09.Actualización de narrativa • Feb 04
DLB: Ongoing Technology Adoption Will Support Returns Despite Choppy Macro Conditions
Analysts have trimmed their price targets on Dolby Laboratories to a range of about $85 to $95. This reflects a more cautious stance on the stock while still pointing to solid recent results and ongoing technology adoption, even as the macro backdrop pressures some revenue streams.Artículo de análisis • Feb 02
Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...Actualización de narrativa • Jan 21
DLB: Technology Adoption And Solid Execution Will Support Future Share Gains
Narrative Update on Dolby Laboratories The analyst price target for Dolby Laboratories has shifted down to a range of about $85 to $95 per share. Analysts point to a solid fiscal Q4, guidance in line with expectations, and continued technology adoption despite macro headwinds as key reasons for the updated view.Actualización de narrativa • Jan 06
DLB: Steady Outlook Will Balance Macro Pressures And Expanding Technology Adoption
Analysts have trimmed their price targets for Dolby Laboratories, with recent moves from $100 to $95 and from $95 to $85, as they weigh steady guidance and progress in technology adoption against ongoing macro headwinds affecting foundational revenues. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Dolby Laboratories even as they acknowledge stable guidance and a solid fiscal fourth quarter.Artículo de análisis • Jan 05
Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?
Key Insights The projected fair value for Dolby Laboratories is US$109 based on 2 Stage Free Cash Flow to Equity...Actualización de narrativa • Dec 21
DLB: Cautious Outlook Will Weigh On Shares Despite Expanding Technology Adoption
Analysts have trimmed their fair value estimate for Dolby Laboratories from $74.00 to $68.00, citing slightly higher discount-rate assumptions despite improving revenue growth and profit margin expectations. They continue to support maintaining a constructive long term outlook.Actualización de narrativa • Dec 07
DLB: Durable Business Model Will Support Future Gains Despite Macro Headwinds
Analysts have trimmed their price targets for Dolby Laboratories by roughly 10 dollars to reflect ongoing macro headwinds to foundational revenues. At the same time, they highlight solid quarterly execution and continued adoption of the company’s technologies as support for maintaining positive ratings.Actualización de narrativa • Nov 23
DLB: Durable Business Model Will Support Long-Term Stability Amid Macroeconomic Headwinds
Analysts have reduced their fair value price target for Dolby Laboratories from $95.75 to $90.50, citing continued macroeconomic headwinds but also recognizing progress in revenue growth and profitability. Analyst Commentary Recent Street research highlights a mix of optimism about Dolby Laboratories' underlying business strengths and caution regarding ongoing macroeconomic challenges.Artículo de análisis • Nov 11
The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Artículo de análisis • Sep 27
Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...Actualización de narrativa • Sep 06
Expanding Auto And Device Ecosystems Will Define Immersive Entertainment
Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.Artículo de análisis • Jul 28
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
While Dolby Laboratories, Inc. ( NYSE:DLB ) might not have the largest market cap around , it had a relatively subdued...Artículo de análisis • May 27
Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 33% Below Their Intrinsic Value Estimate
Key Insights Dolby Laboratories' estimated fair value is US$112 based on 2 Stage Free Cash Flow to Equity Dolby...Seeking Alpha • Feb 07
Dolby Laboratories Remains Fully Valued On Slow Growth
Summary Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 million in cash and no debt, but stock performance has significantly underperformed the benchmark iShares Expanded Technology-Software ETF. Revenue growth was guided at 3.2% for the current fiscal year, with potential upside in mobile and cinema products, but major catalysts are unlikely. Despite moderate growth expectations and a full stock price valuation, I maintain a Neutral rating on DLB stock due to limited upside potential. Read the full article on Seeking AlphaPrevisiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 9/30/2028 | 1,546 | 347 | 541 | 569 | 2 |
| 9/30/2027 | 1,464 | 296 | 499 | 527 | 4 |
| 9/30/2026 | 1,406 | 257 | 341 | 368 | 4 |
| 3/27/2026 | 1,365 | 244 | 265 | 338 | N/A |
| 12/26/2025 | 1,339 | 241 | 386 | 420 | N/A |
| 9/26/2025 | 1,349 | 255 | 430 | 472 | N/A |
| 6/27/2025 | 1,347 | 264 | 438 | 466 | N/A |
| 3/28/2025 | 1,320 | 257 | 390 | 419 | N/A |
| 12/27/2024 | 1,315 | 263 | 395 | 426 | N/A |
| 9/27/2024 | 1,274 | 262 | 297 | 327 | N/A |
| 6/28/2024 | 1,259 | 212 | 265 | 296 | N/A |
| 3/29/2024 | 1,269 | 190 | 365 | 396 | N/A |
| 12/29/2023 | 1,280 | 188 | 290 | 319 | N/A |
| 9/29/2023 | 1,300 | 201 | 337 | 367 | N/A |
| 6/30/2023 | 1,287 | 219 | 301 | 333 | N/A |
| 3/31/2023 | 1,279 | 242 | 348 | 385 | N/A |
| 12/30/2022 | 1,237 | 183 | 303 | 343 | N/A |
| 9/30/2022 | 1,254 | 184 | 259 | 319 | N/A |
| 7/1/2022 | 1,261 | 201 | 316 | 377 | N/A |
| 4/1/2022 | 1,258 | 216 | 314 | 377 | N/A |
| 12/31/2021 | 1,243 | 255 | 332 | 397 | N/A |
| 9/24/2021 | 1,281 | 310 | 393 | 448 | N/A |
| 6/25/2021 | 1,267 | 293 | 398 | 451 | N/A |
| 3/26/2021 | 1,228 | 306 | 359 | 413 | N/A |
| 12/25/2020 | 1,260 | 318 | 334 | 395 | N/A |
| 9/25/2020 | 1,162 | 231 | 275 | 344 | N/A |
| 6/26/2020 | 1,189 | 248 | 287 | 362 | N/A |
| 3/27/2020 | 1,245 | 221 | 234 | 319 | N/A |
| 12/27/2019 | 1,231 | 206 | N/A | 302 | N/A |
| 9/27/2019 | 1,242 | 255 | N/A | 328 | N/A |
| 6/28/2019 | 1,183 | 238 | N/A | 309 | N/A |
| 3/29/2019 | 1,096 | 201 | N/A | 360 | N/A |
| 12/28/2018 | 1,057 | 193 | N/A | 392 | N/A |
| 9/28/2018 | 1,055 | 42 | N/A | 352 | N/A |
| 6/29/2018 | 1,056 | 37 | N/A | 321 | N/A |
| 3/30/2018 | 1,147 | 110 | N/A | 317 | N/A |
| 12/29/2017 | 1,115 | 95 | N/A | 324 | N/A |
| 9/29/2017 | 1,080 | 206 | N/A | 378 | N/A |
| 6/30/2017 | 1,072 | 204 | N/A | 370 | N/A |
| 3/31/2017 | 1,044 | 192 | N/A | 359 | N/A |
| 12/30/2016 | 1,051 | 208 | N/A | 360 | N/A |
| 9/30/2016 | 1,026 | 186 | N/A | 360 | N/A |
| 7/1/2016 | 1,025 | 208 | N/A | 367 | N/A |
| 4/1/2016 | 980 | 180 | N/A | 288 | N/A |
| 1/1/2016 | 977 | 171 | N/A | 373 | N/A |
| 9/25/2015 | 971 | 181 | N/A | 309 | N/A |
| 6/26/2015 | 965 | 181 | N/A | 316 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (14.2% al año) de DLB es superior a la tasa de ahorro (3.5%).
Beneficios vs. Mercado: Se prevé que los beneficios (14.2% al año) de DLB crezcan menos que el mercado US (16.8% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de DLB crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (4.8% al año) de DLB crezcan más despacio que el mercado de US (11.7% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 4.8% al año) de DLB crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de DLB se prevé que sea elevada dentro de 3 años.
Descubre empresas en crecimiento
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/24 07:13 |
| Precio de las acciones al final del día | 2026/05/22 00:00 |
| Beneficios | 2026/03/27 |
| Ingresos anuales | 2025/09/26 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Dolby Laboratories, Inc. está cubierta por 13 analistas. 4 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Vikram Kesavabhotla | Baird |
| Patrick Sholl | Barrington Research Associates, Inc. |
| Eric Wold | B. Riley Securities, Inc. |